Showing results (781-790 of 927) with videos related to
Sort By:
Pageof 93
Genes, Chromosomes & Cancer|August 5, 2005
Genomic profiling of myeloid sarcoma by array comparative genomic hybridizationGeorge Deeb, Maria R Baer, Daniel P Gaile, et al.Mutation Research|June 30, 2006
Genomic instability of human aberrant crypt foci measured by inter-(simple sequence repeat) PCR and array-CGHSadir J Alrawi, Robert E Carroll, Hank C Hill, et al.Cardiovascular Research|March 30, 2013
Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivityMassimiliano Memo, Man-Ching Leung, Douglas G Ward, et al.Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|August 30, 2017
Variable cardiac α-actin (Actc1) expression in early adult skeletal muscle correlates with promoter methylationJordan K Boutilier, Rhonda L Taylor, Ramesh Ram, et al.Genomics|April 15, 1997
A sequence-ready high-resolution physical map of the best macular dystrophy gene region in 11q12-q13P R Cooper, N J Nowak, M J Higgins, et al.The New England Journal of Medicine|April 9, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia GravisRichard J Nowak, Michael Benatar, Emma Ciafaloni, et al.Annals of Clinical and Translational Neurology|December 8, 2023
Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extensionRichard J Nowak, Ari Breiner, Vera Bril, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 4, 2026
Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimodFatemeh Khani-Habibabadi, Fien M Verhamme, Mahan Moshir, et al.Transplantation Proceedings|October 26, 2010
Association of HLA haplotypes with paroxysmal nocturnal hemoglobinuriaJ Nowak, R Mika-Witkowska, E Mendek-Czajkowska, et al.Cancer|April 2, 2011
Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemiaMeir Wetzler, Chris Andrews, Laurie A Ford, et al.Pageof 93